O. Chinot

Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme (2005)

Barrié, M., Couprie, C., Dufour, H., Figarella-Branger, D., Muracciole, X., Hoang-Xuan, K., ...

Background:: The aim of this study was to evaluate the efficacy and safety of carmustine (BCNU) in combination with temozolomide as first-line chemotherapy before and after radiotherapy (RT) in...

Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme (2005)

Barrié, M., Couprie, C., Dufour, H., Figarella-Branger, D., Muracciole, X., Hoang-Xuan, K., ...

Background: The aim of this study was to evaluate the efficacy and safety of carmustine (BCNU) in combination with temozolomide as first-line chemotherapy before and after radiotherapy (RT) in...

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971 (2003)

Taphoorn, M J B, Brandes, A A, Stupp, R, Frenay, M, ...

PURPOSE: Oligodendroglial tumors are chemotherapy-sensitive tumors, with two thirds of patients responding to combination chemotherapy with procarbazine, lomustine, and vincristine (PCV)....

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 (2003)

Chinot, O., Boogerd, W., Bravo Marques, J., Taphoorn, M.J., Kros, J.M., ...

BACKGROUND: Oligodendroglial tumors are chemosensitive, with two-thirds of patients responding to PCV combination chemotherapy with procarbazine, lomustine (CCNU) and vincristine. Temozolomide (TMZ),...

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 (2003)

Van Den Bent, M. J., Chinot, O., Boogerd, W., Bravo Marques, J., Taphoorn, M. J. B., Kros, J. M., ...

Background: Oligodendroglial tumors are chemosensitive, with two-thirds of patients responding to PCV combination chemotherapy with procarbazine, lomustine (CCNU) and vincristine. Temozolomide (TMZ),...

Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

Romain, S., Chinot, O., Klijn, J. G., Van Putten, W. L., Guirou, O., Look, M., ...

Tyrosine-specific protein kinase (TPK) has been associated with the cytoplasmic domain of growth factor receptors as well as oncoproteins. Enzymatic activation appears to be a major initial event in...

Clinical implications of quantitative real-time RT–PCR analysis of hTERT gene expression in human gliomas

Tchirkov, A, Rolhion, C, Kémény, J-L, Irthum, B, Puget, S, Khalil, T, ...

Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002)

Frappaz, D, Chinot, O, Bataillard, A, Ben Hassel, M, Capelle, L, Chanalet, S, ...